Summary
Four of the seven GRUS-3 satellites launched on July 7, 2026 were determined to have permanent failures in their high-speed communications systems. The company has already booked an impairment loss of JPY 1,879M as an extraordinary loss in 1Q FY5/27 and revised full-year revenue guidance down from JPY 9,000M to JPY 6,700M. Accordingly, the focus of the 1Q results is less on the absolute P&L level than on the initial progress against the revenue breakdown underpinning the revised plan — AxelGlobe JPY 4,240M and AxelLiner JPY 2,460M. We also want to confirm where net assets post-extraordinary loss and cash and deposits at end-1Q stand relative to the quarter-end financial covenants attached to the company's borrowings (positive net assets; cash and deposits of at least JPY 2B). The target for commencing commercial operation of the three surviving satellites is February 2027, so that contribution will only be reflected from 3Q onward and should be assessed separately. Even after the revision, revenue represents roughly 2.7x the prior year, making this the quarter in which the initial monetization momentum built on the Ministry of Defense's "Satellite Constellation Development and Operation Project" will be tested.
Key Points for Next Quarter
| Key Points & Focus | Implications |
|---|---|
Revenue Ramp-Up1Q revenue and progress against the revised full-year plan; segment breakdown | The starting point is growth versus 1Q revenue of JPY 308M a year earlier. The revised full-year JPY 6,700M breaks down into AxelGlobe JPY 4,240M and AxelLiner JPY 2,460M, with the initial recognition at AxelGlobe — including defense-related work — the key focus. |
Extraordinary Loss and EquityNet assets and equity ratio after booking the JPY 1,879M impairment loss | Net assets at end-FY5/26 were JPY 6,993M with an equity ratio of 47.7%. The loan agreement with Sumitomo Mitsui Banking Corporation requires net assets to remain positive at each quarter-end, so the post-booking balance warrants checking. |
Liquidity on HandCash and deposits at end-1Q and operating cash flow | Cash and deposits at end-FY5/26 were JPY 5,815M, with operating CF of ▲JPY 5,123M. The same agreement requires maintaining at least JPY 2B in cash and deposits at each quarter-end, making the quarterly cash burn pace critical. |
GRUS-3 Operational ProgressStatus of the three surviving satellites, timing of commercial operation start, and the report from the GRUS-3 anomaly advisory board | The target for commercial operation start is February 2027, with P&L contribution from 3Q onward. The 1Q results will be watched for the operating policy and progress on root-cause investigation. |
AxelLiner Order BaseOutcome of contract negotiations with Pale Blue and progress on the K Program and AL Lab | AxelLiner posted FY5/26 revenue of JPY 1,522M (+14.8%), with the revised full-year plan at JPY 2,460M. The outcome of the negotiations could change the assumptions for AL Lab revenue recognition. |
Key Issues from Previous Results (FY5/26 Full-Year Results)
FY5/26 revenue rose 58.1% to JPY 2,508M, with defense-related projects driving the top line. However, R&D expensing for in-house satellites — including the performance verification satellite "GRUS-3α" and high-resolution satellites — widened the operating loss to JPY 3,822M and the recurring loss to JPY 3,712M. The IPO raised JPY 7.935B, lifting the equity ratio to 47.7%. Yet following the full-year guidance revision triggered by the GRUS-3 anomaly, FY5/27 now puts both the monetization timeline and the capital/liquidity position under simultaneous scrutiny.
1. Initial Momentum in 1Q Toward the Revised Full-Year Plan of JPY 6,700M
- Prior Year: Revenue of JPY 2,508M (+58.1%), of which AxelGlobe JPY 986M (+278.6%) and AxelLiner JPY 1,522M (+14.8%).
- To Watch This Year: The company revised FY5/27 full-year revenue guidance from JPY 9,000M to JPY 6,700M, comprising AxelGlobe JPY 4,240M and AxelLiner JPY 2,460M. Even revised, this is roughly 2.7x the prior year, so we will check the amount recognized at the 1Q stage and the pace of order backlog conversion.
- Key Metrics: 1Q revenue (JPY 308M in the year-ago quarter); segment revenue as a percentage of the revised full-year plan.
2. Booking of the JPY 1,879M Impairment Loss and Financial Covenants
- Prior Year: Year-end net assets of JPY 6,993M, equity ratio of 47.7%; construction in progress increased by JPY 3.335142B, largely on GRUS-3 manufacturing.
- To Watch This Year: Following the GRUS-3 anomaly, the company disclosed that it will book an impairment loss of JPY 1,879M as an extraordinary loss in 1Q FY5/27. The agreement with Sumitomo Mitsui Banking Corporation requires net assets to be positive at each quarter-end, so we will check where net assets and the equity ratio land post-booking. Note that the anomaly is not covered by insurance.
- Key Metrics: End-1Q net assets, equity ratio, breakdown of extraordinary losses.
3. Liquidity on Hand and Funding Headroom
- Prior Year: Year-end cash and deposits of JPY 5.815658B; cash and cash equivalents of JPY 4.715658B. Operating CF ▲JPY 5.123804B, investing CF ▲JPY 2.117392B, financing CF +JPY 7.834911B. Undrawn borrowing capacity of JPY 3.058108B.
- To Watch This Year: The end-1Q balance against the financial covenant requiring at least JPY 2B in cash and deposits at each quarter-end, plus the quarterly cash outflow pace tied to R&D and satellite manufacturing. Management has signaled a policy of securing, expanding and diversifying funding sources including public equity offerings, so any commentary on additional fundraising is also in focus.
- Key Metrics: End-1Q cash and deposits, quarterly operating CF, undrawn borrowing capacity.
4. GRUS-3 Root-Cause Investigation and Commercial Operation Timeline
- Prior Year: Disclosed the launch of seven medium-resolution GRUS-3 satellites on July 7, 2026 (JST), with plans to build a constellation capable of near-daily imaging.
- To Watch This Year: Four satellites were deemed to have permanent failures in their high-speed communications systems, and the company has abandoned commercial operation via image data downlink over those systems. The cause is presumed to be high-temperature damage to amplifier elements due to insufficient heat dissipation in the power amplifier. Because the three functioning satellites share the same design, initial operations are being continued cautiously one satellite at a time with reduced power consumption and communication time, and the target for commercial operation start has been pushed back two months to February 2027. P&L contribution comes from 3Q onward, so the 1Q results will center on operational progress and the status of the review by the external "GRUS-3 Anomaly Verification Advisory Board."
- Key Metrics: Whether the commercial operation start target is maintained; the policy for utilizing the low-speed communications systems on the four affected satellites; any change to the plan for roughly 30 satellites in operation by end-FY5/31.
5. AxelLiner's Revenue Base and the Pale Blue Project
- Prior Year: AxelLiner revenue of JPY 1,522M (+14.8%), gross profit of JPY 139M (▲7.4%), segment loss of JPY 277M. NEDO subsidy income of JPY 487.149M booked in non-operating income.
- To Watch This Year: The company received written notice from Pale Blue regarding termination of the Hall thruster in-orbit demonstration service contract and began discussions on October 6. Pale Blue reportedly concluded that securing commercial viability would be difficult due to satellite-specific technical issues on the Axelspace-developed project; the company explains this is unrelated to the GRUS-3 anomaly. We will also check manufacturing progress on the two K Program demonstration satellites and the status of AL Lab deliveries to JAXA.
- Key Metrics: AxelLiner segment revenue and profit/loss, progress of revenue recognition under the cost-proportional method, and subsidy income in non-operating income.
Major Timely Disclosures During the Current Fiscal Year
- 2026/10/06Notice Regarding Revision of Full-Year Earnings Guidance for FY5/27 and Recognition of Extraordinary Loss — Revenue guidance cut from JPY 9,000M to JPY 6,700M and net loss attributable to owners of the parent revised from JPY 240M to JPY 3,650M, with an impairment loss of JPY 1,879M booked in 1Q. The revision conservatively incorporates the maximum impact estimable at this point, making the 1Q results the venue for validating the revised assumptions.
- 2026/10/06(Progress on Disclosed Matters) Status Report on the Anomaly in the "GRUS-3" Small Satellites of the AxelGlobe Business and Establishment of the "GRUS-3 Anomaly Verification Advisory Board" — Confirms the determination of permanent high-speed communications failures on four satellites, cautious operation of the three survivors, and a February 2027 target for commercial operation start. The external review is scheduled to deliver a final report roughly 1.5 months after the board members are confirmed; the credibility of the recurrence-prevention measures will shape the medium-term fleet expansion plan.
- 2026/09/02Notice Regarding Conclusion of a Distributor Agreement with Airbus Defence and Space, a Subsidiary of Aerospace Major AIRBUS Group — Expanded overseas distribution broadens AxelGlobe's imagery sales base. Since translating this into actual demand requires restored imaging capacity, we will look for commentary on the timing of revenue contribution.
Previous Quarter Results (FY5/26 Full-Year Actuals)
The company operates on two pillars: the AxelLiner business, providing one-stop small satellite design, manufacturing and operation, and the AxelGlobe business, supplying imagery data from its own Earth observation satellite network. In FY5/26, the company began image data acquisition work from April 2026 as a partner company on the Ministry of Defense's "Satellite Constellation Development and Operation Project," driving a sharp revenue increase at AxelGlobe. On the other hand, upfront R&D spending on in-house satellites — including the performance verification satellite "GRUS-3α" and high-resolution satellites — widened both the operating and recurring losses YoY. The August listing on the TSE Growth Market raised JPY 7.935B, lifting the equity ratio from 31.8% to 47.7%.
| Item | Amount | YoY | vs. Company Plan | Notes |
|---|---|---|---|---|
| Revenue | JPY 2,508M | +58.1% | - | AxelGlobe expanded to JPY 986M (+278.6%) on new customers centered on the Ministry of Defense |
| Operating Income | ▲JPY 3,822M | Loss widened (prior year ▲JPY 2,495M) | - | Gross profit of JPY 797M (+639.9%) against SG&A rising to JPY 4,620M |
| Recurring Profit | ▲JPY 3,712M | Loss widened (prior year ▲JPY 1,824M) | - | Subsidy income of JPY 487M; interest expense of JPY 347M |
| Net Income | ▲JPY 4,057M | Loss widened (prior year ▲JPY 1,950M) | - | Extraordinary losses of JPY 338M (impairment loss JPY 290M, loss on cancellation of treasury share acquisition rights JPY 47M, etc.) |
| EPS | ▲JPY 65.84 | Loss widened (prior year ▲JPY 44.96) | - | Weighted average shares outstanding of 61,623,530 |
Total income (Non-GAAP, adding subsidy income to revenue) was JPY 2,995M (+29.0%).
Guidance Achievement Rate (Recurring Profit Basis): Not calculated, as the attached earnings release does not disclose a company plan for FY5/26. For reference, the revised FY5/27 plan calls for a recurring loss of JPY 1,700M (versus a recurring loss of JPY 150M prior to the revision).
ENVALITH, INC. ("ENVALITH") provides exclusive research coverage services to domestic and international institutional investors, as well as domestic individual investors, with the objective of contributing to the development of global and Japanese capital markets by providing information necessary for considering investments in Japanese listed companies.
- Purpose and Disclaimer Regarding Investment Decisions
This report has been prepared solely for informational purposes and does not constitute a solicitation to acquire, sell, or hold securities or any other financial products. Furthermore, this report does not constitute specific investment, financial, or tax advice. Any opinions, judgments, or recommendations contained herein are not intended to induce investment activities. Please be advised that all investment decisions must be made based on the investor's own responsibility and judgment, and ENVALITH and subject company shall not be involved in any such investment decisions.
- Information Sources, Accuracy, and Disclaimer of Warranty
This report has been prepared based on a formal request from the subject company, utilizing information provided by and interviews conducted with said company. By using this report, you are deemed to have agreed to the following: 1. Information Sources: This report is prepared on the assumption that the publicly available information and information disclosed by the subject company and provided during interviews is true and reliable. ENVALITH has not independently verified or validated the veracity of such information. 2. Accuracy: The interpretations, analyses, and hypotheses or conclusions based thereon contained in this report are independently derived by ENVALITH using its own perspectives and analytical methods based on the information mentioned in the preceding paragraph. 3. Disclaimer of Warranty: In the event that there are errors or omissions in the information disclosed by the subject company, ENVALITH and subject company shall not be held liable for any inaccuracies in this report resulting therefrom. ENVALITH and subject company make no warranties, whether express or implied, regarding the accuracy, safety, validity, completeness, or any other aspect of this report, nor regarding the past or future performance of the subject company.
- Limitation of Liability
ENVALITH and subject company shall not be liable for any costs, damages, or losses (including direct, indirect, incidental, consequential, or punitive damages) arising from the use of this report or the information obtained therefrom. Users of this report acknowledge and agree that such use is at their own risk.
- Potential Conflicts of Interest
ENVALITH may have, or may have in the future, business relationships with the subject company. Accordingly, investors should be aware that conflicts of interest may exist that could affect the objectivity of this report.
- No Obligation to Change or Update Content
The contents and opinions in this report, as well as the information upon which it is based, are current as of the date of preparation and are subject to change without notice. Please be advised that ENVALITH is under no obligation to update the contents of this report, and investors must verify the timeliness of the information on their own.
- Governing Language
This report is prepared in Japanese, English, and Chinese. In the event of any discrepancy or difference in interpretation between the language versions, the Japanese version shall be treated as the original and shall prevail.
- Copyright
All rights (including copyrights) relating to this report belong to ENVALITH. Any reproduction, redistribution, or other use of all or part of this report without the prior written permission of ENVALITH is strictly prohibited.
- Use for Other Investment Products
Except where ENVALITH has provided prior written approval, the use of this report and the trademarks or trade names of ENVALITH or the subject company in connection with the information distribution, transaction, sales promotion, or advertising of any investment products (including derivatives, structured products, investment trusts, or investment assets whose price, return, or performance is based on or linked to this report) is strictly prohibited.